Members: Standard Members

At B&D Consulting (a division of the law firm of  Baker & Daniels LLP), our professionals have decades of experience with reimbursement, advocacy, science policy and regulatory issues. From start-up to Fortune 500 companies, our health & life sciences team provides a full range of integrated business consulting and legal services.

Gov't Affairs and Corp. Communications Research and Consulting

Venture Capital Firm

Consulting Services

Research and private equity specialists in orthopedics

Healthcare advisory and financial services firm

Engineering / Design / Product Development

Venture Capital Firm

With offices and staff across the U.S. and Europe, and a corporate presence throughout the world, our services cover a product's full lifecycle, including product development and regulatory strategy, preclinical development, quality systems and supplier qualifications, documentation and audit, submissions, and post-marketing surveillance. We also offer CE Marking and Authorized Representative services specifically for the EU market. Our multi-lingual, mult-disciplinary Regulatory and Quality practice is comprised of well-know experts previously employed with FDA, EU Competent Authority (CA) and Notified Body, as well as some of today's most technologically advanced companies.  Other practice areas include process optimization and commercialization.

Reimbursement consulting

SV Life Sciences is a leading international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the firm closed its first dedicated life sciences fund in 1994. The SVLS team manages six venture capital funds and a publicly traded investment trust with approximately $2 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health-care services. SVLS has offices in Boston, London and San Francisco.

Venture Capital Firm

Underwriters Laboratories, Inc. (UL) is a regulatory service provider helping medical device companies through the regulatory process. UL is the only provider based in North America offering a complete regulatory solution for today's global medical device market including registration to ISO 13485:2003, QMS Registration for Canada, Technical File approvals for Europe and Japan, InMetro qualification for Brazil, gap assessments for Risk Management to ISO 14971, and FDA 510(k) Third Party Reviews. UL continues to support the medical device industry through ongoing expansion of regulatory services and support of organizations like MDMA who support the medical device industry.

Versant's seasoned investment team, with more than 125 years of venture capital and 115 years of operating experience, seeks to invest in visionary companies targeting segments where there is an opportunity to make significant clinical improvements through innovation. Versant manages four venture funds in excess of $1.6B and is currently investing its latest fund, a $500M fund raised in 2008. 

 Global laboratory supply and distribution company